# Biosysen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biosysen

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Website: www.biosysen.com
- Latest round: Angel (Jul 25, 2022)
- Investors on record: 5

## About

Established in 2019 and based in Beijing, China, Biosysen Ltd. operates as a synthetic biology company that focuses on architected genome design and application. Yu Chen and Kang Kang are the CEO and founder of the company.

The business of the company includes platform technology transformation, self-developed pipeline incubation and strain authorization. The company's products include Wet-lab, Dry-lab, OMICs-lab and Ferm-Foundry. The company focuses on research and development of food, daily chemical and protein drugs. The company adopts architected genome technology.

The company will plan to cooperates with biological manufacturing enterprises, bulk chemical suppliers, pharmaceutical enterprises.

## Funding rounds

- Angel, Jul 25, 2022 — Hong Shan, Linear Capital, Sky 9 Capital, Vitalbridge Capital, MiraclePlus
- Seed, Jul 20, 2021 — Hong Shan, Sky 9 Capital, MiraclePlus

## Investors

- Hong Shan — Seed, Angel
- Sky 9 Capital (https://capitalatlas.ai/funds/sky-9-capital) — Seed, Angel
- MiraclePlus (https://capitalatlas.ai/funds/miracleplus) — Seed, Angel
- Linear Capital (https://capitalatlas.ai/funds/linear-capital) — Angel
- Vitalbridge Capital — Angel